I am pleased to announce that I have been chosen to help lead Mount Sinai Health System's Department of Urology into the future, as the leading center in urologic clinical care and innovative research in the region.
This month I started my new appointment at Mount Sinai Health System as Vice Chairman of Urology, Director of Robotic Surgery for Mount Sinai, St. Luke's, & Roosevelt Hospitals. I am also director of the Comprehensive Kidney Cancer Program at Mount Sinai, and Professor of Urology at Icahn School of Medicine at Mount Sinai Hospital, where I will be continuing my groundbreaking research into prostate and kidney cancer treatment.
At Mount Sinai, I will continue to be involved with clinical trials, feasibility and safety studies of new technology, and health-related quality of life outcomes research. I have recently completed one of the largest decision impact studies evaluating genomic biomarkers for active surveillance in men with low-risk prostate cancer. This study aims to determine how to avoid surgery in men whose cancer is dormant and not life threatening, versus those who have a more aggressive prostate cancer and need treatment.
NYC Robotic Institute will continue to provide the same high-quality, patient-focused care to our prostate and kidney patients at our new Mount Sinai location. To make an appointment at NYC Robotic Institute, call our offices today at 212-241-3919.